Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis

Treatments in Respiratory Medicine

Volumn 4, Issue 4, 2005, Pages 283-287

  Zieglmayer, Ursula P ^a   Horak, Friedrich ^a,c   Toth, Josef ^a   Marks, Bernhard ^a   Berger, Uwe E ^a   Burtin, Bernard ^b  

^a University Clinic Vienna   (Austria)

^b UCB PHARMA   (Belgium)

^c Department of Dermatology   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BUDESONIDE; CETIRIZINE; DECONGESTIVE AGENT; PSEUDOEPHEDRINE;

ADULT; ALLERGIC RHINITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; NOSE CAVITY; NOSE CONGESTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOMANOMETRY; TIME SERIES ANALYSIS;

ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ADULT; ANTI-ALLERGIC AGENTS; BUDESONIDE; CETIRIZINE; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; DRUG COMBINATIONS; EPHEDRINE; FEMALE; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MALE; NASAL DECONGESTANTS; PULMONARY VENTILATION; RHINITIS, ALLERGIC, PERENNIAL; RHINOMANOMETRY;

EID: 24344501123     PISSN: 11763450     EISSN: None     Source Type: Journal    
DOI: 10.2165/00151829-200504040-00006     Document Type: Article

References (10)

1. Bousquet J, Van Cauwenberge P, Khaltaev N, et al. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001 Nov; 104 (5 Suppl.): S147-334
2. Sussman GL, Mason J, Compton D, et al. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. J Allergy Clin Immunol 1999 Jul; 104 (1): 100-6
3. Bertrand B, Jamart J, Marchal JL, et al. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology 1996 Jun; 34 (2): 91-6
4. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal rhinitis. J Allergy Clin Immunol 1995 Aug; 96 (2): 139-47
5. Clement PA. Committee report on standardization of rhinomanometry. Rhinology 1984 Sep; 22 (3): 151-5
6. Koch GG. The use of non-parametric methods in the statistical analysis of the two-period change-over design. Biometrics 1972 Jun; 28 (2): 577-84
7. Horak F, Toth J, Marks B, et al. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-released pseudoephedrine in the management of nasal congestion. Allergy 1998 Sep; 53 (9): 849-56
8. Stübner UP, Toth J, Marks B, et al. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Arzneimittel Forschung 2001 Nov; 51 (11): 904-10
9. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis [published erratum appears in Drugs 1992 Dec; 44 (6): 1012 and 1993 Jan; 45 (1): 130]. Drugs 1992; 44 (3): 375-407
10. Day JH, Briscoe MP, Rafeiro E, et al. Onset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol 2000 Mar; 105 (3): 489-94